Chen‐Hong Ding

745 total citations
21 papers, 533 citations indexed

About

Chen‐Hong Ding is a scholar working on Molecular Biology, Epidemiology and Cell Biology. According to data from OpenAlex, Chen‐Hong Ding has authored 21 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Cell Biology. Recurrent topics in Chen‐Hong Ding's work include RNA modifications and cancer (5 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Chen‐Hong Ding is often cited by papers focused on RNA modifications and cancer (5 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Chen‐Hong Ding collaborates with scholars based in China and United States. Chen‐Hong Ding's co-authors include Wei‐Fen Xie, Xin Zhang, Jin Ding, Jinpei Liu, Cheng Luo, Shijie Chen, Wenping Xu, Kai Ding, Jifeng Feng and Chuan Yin and has published in prestigious journals such as Nature Communications, Cancer Research and Gut.

In The Last Decade

Chen‐Hong Ding

19 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen‐Hong Ding China 10 386 224 99 71 61 21 533
Katharine Grimmer United States 6 339 0.9× 250 1.1× 192 1.9× 83 1.2× 92 1.5× 10 595
Kwan Man Hong Kong 5 543 1.4× 199 0.9× 72 0.7× 73 1.0× 44 0.7× 5 688
Yongshen Niu China 13 397 1.0× 336 1.5× 68 0.7× 120 1.7× 51 0.8× 18 601
Yibin Ren China 12 365 0.9× 163 0.7× 90 0.9× 149 2.1× 85 1.4× 13 531
Shrabasti Roychoudhury United States 12 381 1.0× 144 0.6× 72 0.7× 87 1.2× 32 0.5× 17 502
Veronica Yee-Law Leong Hong Kong 6 338 0.9× 115 0.5× 87 0.9× 155 2.2× 32 0.5× 6 478
Noélia Che China 7 282 0.7× 167 0.7× 44 0.4× 103 1.5× 58 1.0× 10 424
Aislinn E. Treloar Canada 4 232 0.6× 108 0.5× 178 1.8× 45 0.6× 49 0.8× 4 431
Gao‐Min Liu China 9 267 0.7× 232 1.0× 78 0.8× 87 1.2× 36 0.6× 16 461
Kequan Xu China 12 387 1.0× 287 1.3× 43 0.4× 85 1.2× 46 0.8× 19 517

Countries citing papers authored by Chen‐Hong Ding

Since Specialization
Citations

This map shows the geographic impact of Chen‐Hong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Hong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Hong Ding more than expected).

Fields of papers citing papers by Chen‐Hong Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Hong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Hong Ding. The network helps show where Chen‐Hong Ding may publish in the future.

Co-authorship network of co-authors of Chen‐Hong Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Hong Ding. A scholar is included among the top collaborators of Chen‐Hong Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Hong Ding. Chen‐Hong Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ding, Chen‐Hong, Binghe Xu, Hui Qian, et al.. (2025). PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma. Cell Death and Disease. 16(1). 158–158. 11 indexed citations
3.
Huang, Chenkai, Hui Qian, Chen‐Hong Ding, et al.. (2025). Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance. Nature Communications. 16(1). 87–87. 6 indexed citations
4.
Liu, Shuqing, Chuan Yin, Xing Deng, et al.. (2025). SOX9 promotes hepatocyte proliferation via upregulating TGF-α expression during liver regeneration. Hepatology International.
5.
Luo, Yuanyuan, Yarong Hao, Chunyan Sun, et al.. (2025). Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut‒liver axis. Cellular and Molecular Immunology. 22(11). 1414–1426. 1 indexed citations
6.
Qian, Hui, Chen‐Hong Ding, Fang Liu, et al.. (2024). SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors. Signal Transduction and Targeted Therapy. 9(1). 96–96. 8 indexed citations
7.
Yu, Peng, Wenping Xu, Chen‐Hong Ding, et al.. (2024). Tripartite motif 8 promotes the progression of hepatocellular carcinoma via mediating ubiquitination of HNF1α. Cell Death and Disease. 15(6). 416–416. 2 indexed citations
8.
Jiang, Nan, Lilin Chen, Fang Liu, et al.. (2024). TRIB3–TRIM8 complex drives NAFLD progression by regulating HNF4α stability. Journal of Hepatology. 80(5). 778–791. 27 indexed citations
9.
Wu, Sihan, et al.. (2024). Cell-permeated peptide P-T3H2 inhibits malignancy on hepatocellular carcinoma through stabilizing HNF4α protein. Discover Oncology. 15(1). 752–752. 1 indexed citations
10.
Luo, Yuanyuan, Yiting Lu, Binbin Li, et al.. (2022). Hsa_Circ_0098181 Suppresses Hepatocellular Carcinoma by Sponging miR-18a-3p and Targeting PPARA. Frontiers in Pharmacology. 13. 819735–819735. 12 indexed citations
11.
Xu, Wenping, Kai Ding, Chen‐Hong Ding, et al.. (2021). Deletion ofSox9in the liver leads to hepatic cystogenesis in mice by transcriptionally downregulatingSec63. The Journal of Pathology. 254(1). 57–69. 6 indexed citations
12.
Wang, Xiaoyu & Chen‐Hong Ding. (2021). Polarizing influence of power distance on country of origin effect. 4(2). 223–237. 1 indexed citations
13.
Chen, Shijie, Sen-Hao Xiao, Qin-Juan Sun, et al.. (2020). Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism. Cancer Research. 81(4). 860–872. 105 indexed citations
14.
Xu, Wenping, Jinpei Liu, Jifeng Feng, et al.. (2019). miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy. Gut. 69(7). 1309–1321. 88 indexed citations
15.
Ding, Chen‐Hong, Shijie Chen, Kongkai Zhu, et al.. (2019). Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α. Theranostics. 9(9). 2606–2617. 40 indexed citations
16.
Wen, Liangzhi, Kai Ding, Ze-Rui Wang, et al.. (2018). SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression. Cancer Research. 78(16). 4680–4691. 68 indexed citations
17.
Ding, Chen‐Hong, Chuan Yin, Shijie Chen, et al.. (2018). The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1. Molecular Cancer. 17(1). 63–63. 61 indexed citations
18.
Ding, Chen‐Hong, Fei Chen, Kai Ding, et al.. (2017). p.Q511L mutation of HNF1α in hepatocellular carcinoma suppresses the transcriptional activity and the anti-tumor effect of HNF1α. Biochemical and Biophysical Research Communications. 495(1). 86–91. 8 indexed citations
19.
Qian, Hui, Xing Deng, Chen‐Hong Ding, et al.. (2015). An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells. Cell Research. 25(8). 930–945. 64 indexed citations
20.
Lü, Meiling, Chun‐Yang Pan, Lantian Zhang, et al.. (2013). ING4 inhibits the translation of proto‐oncogene MYC by interacting with AUF1. FEBS Letters. 587(11). 1597–1604. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharine Grimmer Breakdown of academic impact, for papers by Kwan Man Breakdown of academic impact, for papers by Yongshen Niu Breakdown of academic impact, for papers by Yibin Ren Breakdown of academic impact, for papers by Shrabasti Roychoudhury Breakdown of academic impact, for papers by Veronica Yee-Law Leong Breakdown of academic impact, for papers by Noélia Che Breakdown of academic impact, for papers by Aislinn E. Treloar Breakdown of academic impact, for papers by Gao‐Min Liu Breakdown of academic impact, for papers by Kequan Xu
Rankless by CCL
2026